| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/19/2004 | WO2004069806A2 Substituted 2-aminoimidazoles, method for the production thereof, their use as a medicament or as a diagnostic reagent, and medicament containing these compounds |
| 08/19/2004 | WO2004069798A1 Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient |
| 08/19/2004 | WO2004069294A1 Injectable gel-forming compositions based on cross-linked and non-cross-linked polymers and the use thereof |
| 08/19/2004 | WO2004069262A1 Herbal composition comprising commiphora mukul, allium sativum and curcuma longa |
| 08/19/2004 | WO2004069254A2 Use of dipyridamole or mopidamole for treatment and prevention of mmp-9-dependent disorders |
| 08/19/2004 | WO2004069241A1 Therapeutic use of acylglycerols and the nitrogen- and sulphur-containing analogues thereof |
| 08/19/2004 | WO2004069240A2 Use in therapy of endocannabinoid-like compounds |
| 08/19/2004 | WO2004069238A1 Drug for improving prognosis for subarachnoid hemorrhage |
| 08/19/2004 | WO2004069232A2 Egfr tyrosine kinase inhibitor for treating cardiovascular dysfunction |
| 08/19/2004 | WO2004069165A2 Methods and compositions for the treatment of gastrointestinal disorders |
| 08/19/2004 | WO2004069150A2 Oils enriched with diacylglycerols and phytosterol esters for use in the reduction of cholesterol and triglycerides |
| 08/19/2004 | WO2004069142A2 Anti-candida agents for the treatment of prion diseases |
| 08/19/2004 | WO2003092585A3 Controlled release compositions of estradiol metabolites |
| 08/19/2004 | WO2003057134A8 Specific binding agents of human angiopoietin-2 |
| 08/19/2004 | WO2003053364A3 Methods and compositions in treating pain and painful disorders using 1465,1587, 2146, 2207, 32838, 336 and 52908 |
| 08/19/2004 | WO2003049702A8 Vanilloid receptor ligands and their use in treatments |
| 08/19/2004 | WO2003038123A3 Methods to treat diabetes and related conditions based on polymorphisms in the tcf1 gene |
| 08/19/2004 | WO2003032912A8 Treatment of cns disorders using cns target modulators |
| 08/19/2004 | WO2003025149A8 Cell populations which co-express cd49c and cd90 |
| 08/19/2004 | US20040162435 Novel aliphatic compound, method of synthesis, and method of utilization |
| 08/19/2004 | US20040162433 Lipoxin A4 analogs |
| 08/19/2004 | US20040162430 Branched adamantyl and noradamantyl aryl-and aralkylpiperazines with serotonin 5-HT 1A activity |
| 08/19/2004 | US20040162427 Substituted 2,6-diamino-3,5-dicyano-4-aryl-pyridines and their use as adenosine receptor-selective ligands |
| 08/19/2004 | US20040162426 TNF (tumor necrosis factor); for treating conditions such as rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration; tumor metastasis or invasion; periodontal disease and bone disease |
| 08/19/2004 | US20040162422 adenosine derivatives having an acetylene group in the 4' position, which are adenosine A1 agonists; treating ischaemic heart disease, peripheral vascular disease or stroke or patient suffering pain, a CNS disorder, sleep apnoea or emesis |
| 08/19/2004 | US20040162410 Thrombosis therapy; anticoagulants |
| 08/19/2004 | US20040162352 2-{6-[1-Ethyl-3-(4-trifluoromethoxyphenyl)ureido]-5,6,7,8-tetrahydronaphthalen-2-ylsulfanyl}-2-methylpropionic acid or other derivatives of tetralins and indanes; PPAR alpha modulators to treat or inhibit the progression of diabetes |
| 08/19/2004 | US20040162349 Use of polyunsaturated fatty acid for the primary prevention of major cardiovascular events |
| 08/19/2004 | US20040162348 Highly purified ethyl EPA and other EPA derivatives for psychiatric and neurological disorders |
| 08/19/2004 | US20040162344 Effective ingredient and basic agent; foam suppression |
| 08/19/2004 | US20040162339 such as 3-[3-(1-adamantyl)-4-methoxyphenyl]-3-methyl-2H-1-benzofuran-6-carboxylic acid for treatment of psoriasis, dermatitis, acne or seborrhoea; veterinary medicine |
| 08/19/2004 | US20040162334 administering enantiomorphs comprising (Z(+-)-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropanecarboxamide hydrochloride), as serotonin and adrenergic uptake inhibitors, with side effect reduction; antidepressants |
| 08/19/2004 | US20040162330 Stable high-concentration injection containing pyrazolone derivative |
| 08/19/2004 | US20040162329 Structural carotenoid analogs for the inhibition and amelioration of disease |
| 08/19/2004 | US20040162325 phenyloxazole- or thiazole-alkyl-1,3-dioxane or 1,3-dithiane derivatives; therapeutic drugs for lowering blood triglyceride, low-density lipoprotein cholesterol; arteriosclerosis, diabetes mellitus, hypertension, obesity |
| 08/19/2004 | US20040162319 For prophylaxis and therapy of thrombotic conditions including coronary artery and cerebrovascular diseases |
| 08/19/2004 | US20040162314 Enzyme inhibitors of phosphordiesterase 4 having minimal side effects; antiinflammatory agents; antiallergens; asthma; neurodegenerative disorders; antidiabetic agents; pain; anti-tumor, -carcinogenic and -arthritic agents |
| 08/19/2004 | US20040162313 Heterocyclic derivatives |
| 08/19/2004 | US20040162304 Estrogen receptor modulators |
| 08/19/2004 | US20040162302 Novel crystal of arylethenesulfonamide derivative and preparation process thereof |
| 08/19/2004 | US20040162299 Substituted quinazolines and analogs and the use thereof |
| 08/19/2004 | US20040162297 For manufacture of a medicament for use in decreasing plasma free fatty acid concentration; reducing heart rate; or treating ischemic heart disease, peripheral vascular disease, stroke, pain, CNS disorder, or sleep apnoea |
| 08/19/2004 | US20040162295 Pharmaceutical compound |
| 08/19/2004 | US20040162291 For therapy of cardiovascular disorders and erectile dysfunction |
| 08/19/2004 | US20040162290 For therapy of cancer, benign prostatic hypertrophy or myoma of the uterus, endometriosis, polycystic ovarian disease, uterine fibroids or precocious puberty, lupus erythematosis, irritable bowel syndrome, premenstrual syndrome, hirsutism |
| 08/19/2004 | US20040162287 Substituted cyclohexane-1,4-diamine compounds |
| 08/19/2004 | US20040162276 Indazole or indole derivatives, and use thereof in human medicine and more particularly in oncology |
| 08/19/2004 | US20040162257 For inhibiting angiogenesis |
| 08/19/2004 | US20040162248 Preparation and diabetic use of gibberellins |
| 08/19/2004 | US20040162244 Novel peptides use as angiotensin converting enzyme inhibitor and preparation process thereof |
| 08/19/2004 | US20040162241 Use of GLP-1 or analogs in treatment of myocardial infarction |
| 08/19/2004 | US20040162231 Vasodilator pharmaceutical preparation and health food composition |
| 08/19/2004 | US20040161526 Mixing cyclodextrins with food; antidiabetic agents; metabolism disease; obesity; hypotensive agents |
| 08/19/2004 | US20040161430 Dye-azide compounds for dual phototherapy |
| 08/19/2004 | DE10237722A1 Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase Indole or benzimidazole derivatives for the modulation of IkappaB kinase |
| 08/19/2004 | CA2515717A1 Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient |
| 08/19/2004 | CA2515290A1 Oils enriched with diacylglycerols and phytosterol esters for use in the reduction of cholesterol and triglycerides |
| 08/19/2004 | CA2515266A1 Use of dipyridamole or mopidamole for treatment and prevention of mmp-9-dependent disorders |
| 08/19/2004 | CA2515119A1 Pyrazole derivative |
| 08/19/2004 | CA2514301A1 Therapeutic use of acylglycerols and the nitrogen- and sulphur-containing analogues thereof |
| 08/19/2004 | CA2514028A1 Substituted 2-aminoimidazoles, method for the production thereof, their use as a medicament or as a diagnostic reagent, and medicament containing these compounds |
| 08/19/2004 | CA2513529A1 Substituted heterocyclic compounds useful in the treatment of cardiovascular diseases |
| 08/18/2004 | EP1447407A1 Adenosine derivatives |
| 08/18/2004 | EP1447401A1 Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient |
| 08/18/2004 | EP1447399A1 "2-oxo-1-pyrrolidine derivative and its pharmaceutical uses" |
| 08/18/2004 | EP1447095A1 Preventives and/or remedies for post-transplant arteriosclerosis as rejection of organ transplant |
| 08/18/2004 | EP1447090A2 Use of hyaluronidase for preventing and treating cardiovascular diseases |
| 08/18/2004 | EP1447089A2 Methods of treating hypertension and compositions for use therein |
| 08/18/2004 | EP1447088A1 Vasodilator pharmaceutical preparation and health food composition |
| 08/18/2004 | EP1447013A1 Method for reducing the glycemic index of food |
| 08/18/2004 | EP1446487A1 Mammalian protein phosphatases |
| 08/18/2004 | EP1446418A2 Integrin targeting compounds |
| 08/18/2004 | EP1446411A1 Acarbose purification process |
| 08/18/2004 | EP1446407A2 (pyrido/thieno)-(f)-oxazepin-5-one derivatives as positive modulators of the ampa receptor |
| 08/18/2004 | EP1446397A1 Novel mandelate salts of substituted tetracyclic tetrahydrofuran derivatives |
| 08/18/2004 | EP1446396A1 Methods for treating depression and other cns disorders using enantiomerically enriched desmethyl- and didesmethyl-metabolites of citalopram |
| 08/18/2004 | EP1446393A1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase |
| 08/18/2004 | EP1446385A1 Preparation and use of substituted imidazoles |
| 08/18/2004 | EP1446382A1 Anthranilic acid amides and their use as vegf receptor tyrosine kinase inhibitors |
| 08/18/2004 | EP1446381A1 Anthranilic acid amides and pharmaceutical use thereof |
| 08/18/2004 | EP1446380A1 Formoterol tartrate process and polymorph |
| 08/18/2004 | EP1446379A1 Aryl aniline beta-2 adrenergic receptor agonists |
| 08/18/2004 | EP1446155A1 Pharmaceutical composition comprising factor vii polypeptides and aprotinin polypeptides |
| 08/18/2004 | EP1446149A1 Pharmaceutical composition comprising factor vii polypeptides and factor v polypeptides |
| 08/18/2004 | EP1446146A1 Pharmaceutical composition comprising factor vii polypeptides and pai-1 polypeptides |
| 08/18/2004 | EP1446134A1 Compositions comprising organic extracts of geum japonicum thunb var. and the use thereof |
| 08/18/2004 | EP1446131A1 Use of specific dose of fondaparinux sodium for the treatment of acs |
| 08/18/2004 | EP1446127A1 Triazepine derivatives as neurotrophic agents |
| 08/18/2004 | EP1446125A1 Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity |
| 08/18/2004 | EP1446124A1 Combination therapy comprising zd6474 and a taxane |
| 08/18/2004 | EP1446113A2 Compounds and methods for treating transplant rejection |
| 08/18/2004 | EP1446110A2 Organosulfur inhibitors of tyrosine phosphatases |
| 08/18/2004 | EP1446109A1 Methods and compositions for use of (s)-bisoprolol |
| 08/18/2004 | EP1446100A2 Injectable depot compositions and uses thereof |
| 08/18/2004 | EP1446088A2 Intraorally disintegrating valdecoxib compositions prepared by fluid bed granulation process |
| 08/18/2004 | EP1446015A1 Remodeling of tissues and organs |
| 08/18/2004 | EP1446007A1 Methods and compositions for targeting underglycosylated proteins across the blood brain barrier |
| 08/18/2004 | EP1286997B1 6-phenylpyrrolopyrimidinedione derivatives |
| 08/18/2004 | EP1268429B1 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 08/18/2004 | EP1212309B1 Caspase inhibitor |